表: 用于慢性体重管理的 GLP - 1 和 GIP / GLP - 1 受体激动剂。
关键词: Saxenda Wegovy Zepbound adverse effects dosage liraglutide safety semaglutide tirzepatide weight loss
Mesh : Humans Glucagon-Like Peptide-1 Receptor / agonists Glucagon-Like Peptide 1 / agonists Obesity / drug therapy Gastric Inhibitory Polypeptide / therapeutic use Receptors, Gastrointestinal Hormone / agonists Anti-Obesity Agents / adverse effects therapeutic use administration & dosage Weight Loss / drug effects Animals Glucagon-Like Peptide-1 Receptor Agonists
来 源: DOI:10.58347/tml.2024.1708d